THE SUSTAINABLE HEALTHCARE CO
LIVE

Serial Number

90863643

Owner

Patel & Gong, Inc.

Attorney

Francis G. Gleason, Jr.

First Use Date

Nov 18, 2022

Filing Date

Aug 3, 2021

Add to watchlist:

No watchlists yet
View on USPTO

THE SUSTAINABLE HEALTHCARE CO Trademark

Serial Number: 90863643 • Registration: 7311964

THE SUSTAINABLE HEALTHCARE CO is a trademark filed by Patel & Gong, Inc. on August 3, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Patel & Gong, Inc. (7 trademarks)

Washington, DC 20001

Entity Type: 03

Trademark Details

Filing Date

August 3, 2021

Registration Date

February 20, 2024

First Use Anywhere

November 18, 2022

First Use in Commerce

November 18, 2022

Goods & Services

Analgesic and muscle relaxant pharmaceutical preparations; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent swelling in the legs

Retail pharmacy services; Retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; Wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 20, 2024 NRCS
REGISTERED-SUPPLEMENTAL REGISTER
Feb 20, 2024 R.SR
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Jan 17, 2024 AAUA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Jan 16, 2024 CNTA
USE AMENDMENT ACCEPTED
Jan 16, 2024 IUAA
EXAMINER'S AMENDMENT ENTERED
Dec 26, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 26, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 26, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 26, 2023 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 28, 2023 GNRN
NON-FINAL ACTION E-MAILED
Aug 28, 2023 GNRT
NON-FINAL ACTION WRITTEN
Aug 28, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 9, 2023 TEME
AMENDMENT TO USE PROCESSING COMPLETE
Aug 9, 2023 AUPC
USE AMENDMENT FILED
Aug 9, 2023 IUAF
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 8, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 8, 2023 TROA
TEAS AMENDMENT OF USE RECEIVED
Aug 8, 2023 EAAU
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 8, 2023 GNRN
NON-FINAL ACTION E-MAILED
May 8, 2023 GNRT
NON-FINAL ACTION WRITTEN
May 8, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 20, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 20, 2023 CRFA
ASSIGNED TO LIE
Apr 20, 2023 ALIE
NOTICE OF REVIVAL - E-MAILED
Jan 24, 2023 NREV
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 23, 2023 TROA
PETITION TO REVIVE-GRANTED
Jan 23, 2023 PETG
TEAS PETITION TO REVIVE RECEIVED
Jan 23, 2023 PROA
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Nov 21, 2022 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Nov 21, 2022 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 21, 2022 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 6, 2022 GNRN
NON-FINAL ACTION E-MAILED
May 6, 2022 GNRT
NON-FINAL ACTION WRITTEN
May 6, 2022 CNRT
ASSIGNED TO EXAMINER
Apr 29, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 8, 2021 NWOS
NEW APPLICATION ENTERED
Aug 6, 2021 NWAP